טוען...
Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients
BACKGROUND: We characterized the pharmacogenomics (PGx) results received by diagnostic odyssey patients as secondary findings during clinical whole exome sequencing (WES) testing as a part of their care in Mayo Clinic's Individualized Medicine Clinic to determine the potential benefits and limi...
שמור ב:
| הוצא לאור ב: | Mol Genet Genomic Med |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5441410/ https://ncbi.nlm.nih.gov/pubmed/28546997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mgg3.283 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|